FY2024 EPS Estimates for Ayr Wellness Reduced by Analyst

Ayr Wellness Inc. (OTCMKTS:AYRWF) – Equities researchers at Roth Capital dropped their FY2024 earnings estimates for shares of Ayr Wellness in a note issued to investors on Wednesday, November 13th. Roth Capital analyst W. Kirk now anticipates that the company will post earnings per share of ($1.40) for the year, down from their previous estimate of ($1.22). Roth Capital has a “Strong-Buy” rating on the stock. The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.30) per share. Roth Capital also issued estimates for Ayr Wellness’ Q4 2024 earnings at ($0.34) EPS, Q1 2025 earnings at ($0.32) EPS, Q2 2025 earnings at ($0.31) EPS, Q3 2025 earnings at ($0.30) EPS, Q4 2025 earnings at ($0.30) EPS and FY2025 earnings at ($1.23) EPS.

Other analysts also recently issued reports about the company. Atb Cap Markets downgraded Ayr Wellness from a “hold” rating to a “strong sell” rating in a research note on Wednesday, November 13th. Roth Mkm dropped their target price on Ayr Wellness from $3.50 to $3.00 and set a “buy” rating on the stock in a report on Thursday, November 14th.

Ayr Wellness Price Performance

Shares of AYRWF opened at $0.77 on Monday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.67 and a current ratio of 1.59. Ayr Wellness has a fifty-two week low of $0.71 and a fifty-two week high of $4.09. The firm has a 50-day simple moving average of $1.79 and a 200-day simple moving average of $1.97. The company has a market capitalization of $87.90 million, a price-to-earnings ratio of -0.35 and a beta of 2.00.

About Ayr Wellness

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.